
Joanne Hama
Supervisory Patent Examiner (ID: 14324, Phone: (571)272-2911 , Office: P/1647 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1647, 1632, 4111 |
| Total Applications | 538 |
| Issued Applications | 98 |
| Pending Applications | 74 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12663919
[patent_doc_number] => 20180113139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/329514
[patent_app_country] => US
[patent_app_date] => 2015-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 1
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329514
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329514 | METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISORDERS | Jul 27, 2015 | Abandoned |
Array
(
[id] => 10467259
[patent_doc_number] => 20150352274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'DIAGNOSIS, MONITORING, AND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 14/732212
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11559
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14732212
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/732212 | Extracorporeal removal of anti-IQCJ antibodies from blood | Jun 4, 2015 | Issued |
Array
(
[id] => 11602551
[patent_doc_number] => 20170119851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'METHODS OF TREATING ANOREXIA'
[patent_app_type] => utility
[patent_app_number] => 15/312437
[patent_app_country] => US
[patent_app_date] => 2015-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18427
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15312437
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/312437 | METHODS OF TREATING ANOREXIA | May 18, 2015 | Abandoned |
Array
(
[id] => 10444621
[patent_doc_number] => 20150329635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'SUPPRESSION OF LEPTIN ACTION FOR TREATMENT OF PULMONARY INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/713754
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6891
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14713754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/713754 | SUPPRESSION OF LEPTIN ACTION FOR TREATMENT OF PULMONARY INFECTIONS | May 14, 2015 | Abandoned |
Array
(
[id] => 11588382
[patent_doc_number] => 20170112792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'ENHANCED ATRA-RELATED COMPOUNDS DERIVED FROM STRUCTURE-ACTIVITY RELATIONSHIPS AND MODELING FOR INHIBITING PIN1'
[patent_app_type] => utility
[patent_app_number] => 15/126714
[patent_app_country] => US
[patent_app_date] => 2015-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 99
[patent_no_of_words] => 68108
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126714
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/126714 | ENHANCED ATRA-RELATED COMPOUNDS DERIVED FROM STRUCTURE-ACTIVITY RELATIONSHIPS AND MODELING FOR INHIBITING PIN1 | Mar 18, 2015 | Abandoned |
Array
(
[id] => 11570827
[patent_doc_number] => 20170109471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'VARIANT ANALYSIS IN HIGH-THROUGHPUT SEQUENCING APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/120193
[patent_app_country] => US
[patent_app_date] => 2015-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7962
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120193
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/120193 | VARIANT ANALYSIS IN HIGH-THROUGHPUT SEQUENCING APPLICATIONS | Feb 18, 2015 | Abandoned |
Array
(
[id] => 11270871
[patent_doc_number] => 20160333418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'Activin Inhibitor Response Prediction and Uses for Treatment'
[patent_app_type] => utility
[patent_app_number] => 15/111034
[patent_app_country] => US
[patent_app_date] => 2015-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28316
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15111034
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/111034 | Activin Inhibitor Response Prediction and Uses for Treatment | Jan 13, 2015 | Abandoned |
Array
(
[id] => 11116375
[patent_doc_number] => 20160313349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'METHOD OF DIAGNOSIS AND TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/104377
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17873
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104377 | METHOD OF DIAGNOSIS AND TREATMENT | Dec 8, 2014 | Abandoned |
Array
(
[id] => 10800681
[patent_doc_number] => 20160146838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'SYSTEM AND METHOD FOR EBOLA DETECTION'
[patent_app_type] => utility
[patent_app_number] => 14/548314
[patent_app_country] => US
[patent_app_date] => 2014-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4164
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14548314
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/548314 | SYSTEM AND METHOD FOR EBOLA DETECTION | Nov 19, 2014 | Abandoned |
Array
(
[id] => 10255565
[patent_doc_number] => 20150140562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'LAB ON CHIP IMAGE ANALYSIS'
[patent_app_type] => utility
[patent_app_number] => 14/543160
[patent_app_country] => US
[patent_app_date] => 2014-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11709
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14543160
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/543160 | LAB ON CHIP IMAGE ANALYSIS | Nov 16, 2014 | Abandoned |
Array
(
[id] => 11129256
[patent_doc_number] => 20160326230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'HUMAN RELAXIN ANALOGUE, PHARMACEUTICAL COMPOSITION OF SAME, AND PHARMACEUTICAL APPLICATION OF SAME'
[patent_app_type] => utility
[patent_app_number] => 15/033421
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15187
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033421
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/033421 | HUMAN RELAXIN ANALOGUE, PHARMACEUTICAL COMPOSITION OF SAME, AND PHARMACEUTICAL APPLICATION OF SAME | Oct 9, 2014 | Abandoned |
Array
(
[id] => 10331930
[patent_doc_number] => 20150216934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'FIBROBLAST GROWTH FACTOR-9 PROMOTES HAIR FOLLICLE REGENERATION AFTER WOUNDING'
[patent_app_type] => utility
[patent_app_number] => 14/505970
[patent_app_country] => US
[patent_app_date] => 2014-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22919
[patent_no_of_claims] => 159
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14505970
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/505970 | FIBROBLAST GROWTH FACTOR-9 PROMOTES HAIR FOLLICLE REGENERATION AFTER WOUNDING | Oct 2, 2014 | Abandoned |
Array
(
[id] => 9812040
[patent_doc_number] => 20150023985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASE OR CONDITION'
[patent_app_type] => utility
[patent_app_number] => 14/328792
[patent_app_country] => US
[patent_app_date] => 2014-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10544
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328792
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/328792 | COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH RESPIRATORY DISEASE OR CONDITION | Jul 10, 2014 | Abandoned |
Array
(
[id] => 9812036
[patent_doc_number] => 20150023980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING AND PREVENTING THE INFECTIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/325455
[patent_app_country] => US
[patent_app_date] => 2014-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23926
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14325455
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/325455 | COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING AND PREVENTING THE INFECTIOUS DISEASES | Jul 7, 2014 | Abandoned |
Array
(
[id] => 9812029
[patent_doc_number] => 20150023972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING AND PREVENTING THE INFECTIOUS DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/324575
[patent_app_country] => US
[patent_app_date] => 2014-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23943
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/324575 | COMBINATION PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING AND PREVENTING THE INFECTIOUS DISEASES | Jul 6, 2014 | Abandoned |
Array
(
[id] => 9641924
[patent_doc_number] => 20140220033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'Administration of an Anti-Activin-A Compound to a Subject'
[patent_app_type] => utility
[patent_app_number] => 14/171670
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 50677
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171670
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/171670 | Administration of an Anti-Activin-A Compound to a Subject | Feb 2, 2014 | Abandoned |
Array
(
[id] => 11066220
[patent_doc_number] => 20160263184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1'
[patent_app_type] => utility
[patent_app_number] => 14/765226
[patent_app_country] => US
[patent_app_date] => 2014-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11592
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765226
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/765226 | METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1 | Feb 2, 2014 | Abandoned |
Array
(
[id] => 10452017
[patent_doc_number] => 20150337031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'BIOMARKER METHODS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/654211
[patent_app_country] => US
[patent_app_date] => 2013-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13243
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654211
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654211 | BIOMARKER METHODS AND COMPOSITIONS | Dec 18, 2013 | Abandoned |
Array
(
[id] => 9670536
[patent_doc_number] => 20140234399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'HIV VACCINE'
[patent_app_type] => utility
[patent_app_number] => 14/132267
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 19326
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14132267
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/132267 | HIV VACCINE | Dec 17, 2013 | Abandoned |
Array
(
[id] => 10422594
[patent_doc_number] => 20150307606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/650605
[patent_app_country] => US
[patent_app_date] => 2013-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11203
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14650605
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/650605 | LYOPHILIZED SPHERICAL PELLETS OF ANTI-IL-23 ANTIBODIES | Dec 8, 2013 | Abandoned |